Class information for:
Level 1: CLINICAL TRIAL RISK//DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
16867 631 31.4 57%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
1464 2             FOOD AND DRUG LAW JOURNAL//CONFLICT OF INTEREST//ORPHAN DRUGS 7747
16867 1                   CLINICAL TRIAL RISK//DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV 631

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CLINICAL TRIAL RISK authKW 290345 1% 100% 6
2 DRUG DISCOVERY TODAY journal 217557 17% 4% 105
3 TUFTS STUDY DRUG DEV address 163506 2% 24% 14
4 STRATEGIE IND address 145172 0% 100% 3
5 ANESTHESIOL PERIOPERAT PAIN MEDMRB address 96782 0% 100% 2
6 ASI AC EMERGING MARKETS address 96782 0% 100% 2
7 DEVELOPMENT PIPELINE FORECASTING authKW 96782 0% 100% 2
8 TOPIC SPECIFIC PUBLICATIONS authKW 96782 0% 100% 2
9 RESEARCH AND DEVELOPMENT PRODUCTIVITY authKW 64520 0% 67% 2
10 3D IMAGING LLC address 48391 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 3876 46% 0% 290
2 Biotechnology & Applied Microbiology 605 14% 0% 90
3 Medical Informatics 382 3% 0% 20
4 Health Care Sciences & Services 260 5% 0% 30
5 Health Policy & Services 245 3% 0% 22
6 Medicine, Research & Experimental 212 8% 0% 50
7 Business 189 3% 0% 22
8 Management 167 4% 0% 25
9 Chemistry, Medicinal 167 6% 0% 35
10 Information Science & Library Science 46 2% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TUFTS STUDY DRUG DEV 163506 2% 24% 14
2 STRATEGIE IND 145172 0% 100% 3
3 ANESTHESIOL PERIOPERAT PAIN MEDMRB 96782 0% 100% 2
4 ASI AC EMERGING MARKETS 96782 0% 100% 2
5 3D IMAGING LLC 48391 0% 100% 1
6 ALZHEIMERS INITIAT 48391 0% 100% 1
7 ANESTHESIA MRB 48391 0% 100% 1
8 BASEL GMBH 48391 0% 100% 1
9 BIOMEDTRACKER 48391 0% 100% 1
10 BIOSCI MANAGEMENT INITIAT 48391 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DRUG DISCOVERY TODAY 217557 17% 4% 105
2 NATURE REVIEWS DRUG DISCOVERY 43423 5% 3% 29
3 THERAPEUTIC INNOVATION & REGULATORY SCIENCE 26101 2% 4% 14
4 SCIENCE TRANSLATIONAL MEDICINE 9894 3% 1% 18
5 NATURE BIOTECHNOLOGY 9744 4% 1% 23
6 CLINICAL PHARMACOLOGY & THERAPEUTICS 4368 4% 0% 23
7 BIOFUTUR 3546 2% 1% 11
8 CTS-CLINICAL AND TRANSLATIONAL SCIENCE 3167 1% 1% 6
9 EXPERT OPINION ON DRUG DISCOVERY 3097 1% 1% 8
10 CHEMICAL & ENGINEERING NEWS 3087 3% 0% 16

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CLINICAL TRIAL RISK 290345 1% 100% 6 Search CLINICAL+TRIAL+RISK Search CLINICAL+TRIAL+RISK
2 DEVELOPMENT PIPELINE FORECASTING 96782 0% 100% 2 Search DEVELOPMENT+PIPELINE+FORECASTING Search DEVELOPMENT+PIPELINE+FORECASTING
3 TOPIC SPECIFIC PUBLICATIONS 96782 0% 100% 2 Search TOPIC+SPECIFIC+PUBLICATIONS Search TOPIC+SPECIFIC+PUBLICATIONS
4 RESEARCH AND DEVELOPMENT PRODUCTIVITY 64520 0% 67% 2 Search RESEARCH+AND+DEVELOPMENT+PRODUCTIVITY Search RESEARCH+AND+DEVELOPMENT+PRODUCTIVITY
5 4SC 203 48391 0% 100% 1 Search 4SC+203 Search 4SC+203
6 ACADEMIC RADIOLOGISTS 48391 0% 100% 1 Search ACADEMIC+RADIOLOGISTS Search ACADEMIC+RADIOLOGISTS
7 ACADEMIC RESEARCH CENTERS 48391 0% 100% 1 Search ACADEMIC+RESEARCH+CENTERS Search ACADEMIC+RESEARCH+CENTERS
8 AD IFN GAMMA 48391 0% 100% 1 Search AD+IFN+GAMMA Search AD+IFN+GAMMA
9 ADVERSE EVENTS REPORTING SYSTEM AERS 48391 0% 100% 1 Search ADVERSE+EVENTS+REPORTING+SYSTEM+AERS Search ADVERSE+EVENTS+REPORTING+SYSTEM+AERS
10 AGS 16M18 48391 0% 100% 1 Search AGS+16M18 Search AGS+16M18

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SCHUHMACHER, A , GASSMANN, O , HINDER, M , (2016) CHANGING R&D MODELS IN RESEARCH-BASED PHARMACEUTICAL COMPANIES.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 14. ISSUE . P. - 17 74% 1
2 DIMASI, JA , GRABOWSKI, HG , HANSEN, RW , (2016) INNOVATION IN THE PHARMACEUTICAL INDUSTRY: NEW ESTIMATES OF R&D COSTS.JOURNAL OF HEALTH ECONOMICS. VOL. 47. ISSUE . P. 20 -33 9 50% 46
3 JULIANO, RL , (2013) PHARMACEUTICAL INNOVATION AND PUBLIC POLICY: THE CASE FOR A NEW STRATEGY FOR DRUG DISCOVERY AND DEVELOPMENT.SCIENCE AND PUBLIC POLICY. VOL. 40. ISSUE 3. P. 393-405 19 59% 5
4 KHANNA, I , (2012) DRUG DISCOVERY IN PHARMACEUTICAL INDUSTRY: PRODUCTIVITY CHALLENGES AND TRENDS.DRUG DISCOVERY TODAY. VOL. 17. ISSUE 19-20. P. 1088-1102 10 83% 87
5 FORSTER, SP , STEGMAIER, J , SPYCHER, R , SEEGER, S , (2014) VIRTUAL PHARMACEUTICAL COMPANIES: COLLABORATING FLEXIBLY IN PHARMACEUTICAL DEVELOPMENT.DRUG DISCOVERY TODAY. VOL. 19. ISSUE 3. P. 348-355 10 100% 2
6 ROBERTSON, GM , MAYR, LM , (2011) COLLABORATION VERSUS OUTSOURCING: THE NEED TO THINK OUTSIDE THE BOX.FUTURE MEDICINAL CHEMISTRY. VOL. 3. ISSUE 16. P. 1995 -2020 21 45% 6
7 KISSIN, I , BRADLEY, EL , (2012) TOP JOURNALS SELECTIVITY INDEX AND "ME-TOO" DRUGS.SCIENTOMETRICS. VOL. 91. ISSUE 1. P. 131-142 9 100% 1
8 WILD, H , HUWE, C , LESSL, M , (2013) "COLLABORATIVE INNOVATION" - REGAINING THE EDGE IN DRUG DISCOVERY.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 52. ISSUE 10. P. 2684-2687 10 83% 5
9 MULLANE, K , WILLIAMS, M , (2012) TRANSLATIONAL SEMANTICS AND INFRASTRUCTURE: ANOTHER SEARCH FOR THE EMPEROR'S NEW CLOTHES?.DRUG DISCOVERY TODAY. VOL. 17. ISSUE 9-10. P. 459 -468 18 45% 6
10 COSTANTINOT, L , BARLOCCO, D , (2016) TEN YEARS OF MEDICINAL CHEMISTRY (2005-2014) IN THE JOURNAL OF MEDICINAL CHEMISTRY: COUNTRY OF CONTRIBUTORS, TOPICS, AND PUBLIC-PRIVATE PARTNERSHIPS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 16. P. 7352 -7359 10 71% 0

Classes with closest relation at Level 1


Rank Class id link
1 36921 WICHITA CLIN TRIALS UNIT//AIRWAY SPLINT//BIOMACROMOLECULE PROTEIN
2 16184 ORPHAN DRUGS//RARE DISEASES//ORPHAN DRUG ACT
3 25741 ANTIBACTERIAL DRUG DEVELOPMENT//INFECT GLOBAL MED DEV//ANTIBIOTIC INNOVATION
4 26445 DRUG LAG//JAPANESE CLINICAL TRIALS//GLOBAL DRUG DEVELOPMENT
5 33716 TARGET BASED DRUG//FULL TIME RESEARCHERS//ACADEMY OF MEDICINE
6 6856 NETWORK PHARMACOLOGY//DRUG REPOSITIONING//SYSTEMS PHARMACOLOGY
7 28722 MANAGEMENT HEALTHCARE//ACADEMIC ASSOCIATE PROGRAM//CLINICAL RESEARCH MANAGEMENT
8 28631 MCLAUGHLIN ROTMAN GLOBAL HLTH//BIOTECH AND PHARMA INDUSTRIES//ESRC INNOGEN
9 35658 RESEARCH WORKFORCE DEVELOPMENT//ASSET COMMERCIALIZATION//BIOMEDICAL WORKFORCE
10 5560 GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC MEDICINES

Go to start page